Common properties for propargylamines of enhancing superoxide dismutase and catalase activities in the dopaminergic system in the rat: Implications for the life prolonging effect of (-)deprenyl

Journal of Neural Transmission, Supplement

Volumn , Issue 60, 2000, Pages 139-156

  Kitani, K ^a   Minami, C ^a   Maruyama, W ^a   Kanai, S ^a   Ivy, G O ^a   Carrillo, M C ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; MONOAMINE OXIDASE B INHIBITOR; N (2 HEPTYL) N METHYLPROPARGYLAMINE; NEUROPROTECTIVE AGENT; RASAGILINE; SELEGILINE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

AGING; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE TIME EFFECT RELATION; DRUG MECHANISM; ENZYME ACTIVATION; LIFE EXPECTANCY; LIFESPAN; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE;

EID: 0034522588     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6301-6_9     Document Type: Conference Paper

References (54)

1. L-deprenyl treatment in aged mice slightly increases life spans, and greatly reduces fecundity by aged males
2. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase
3. Long-term treatment of male F344 rats with deprenyl: Assessment of effects on longevity, behavior, and brain function
4. Symptomatic and neuroprotective properties of the aliphatic propargylamines
5. Aliphatic propargylamines: New antiapoptotic drugs
6. Deprenyl induces activities of both superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male rats
7. Deprenyl increases activities of superoxide dismutase and catalase in striatum but not in hippocampus: The sex and age-related differences in the optimal dose in the rat
8. Sequential changes in activities of superoxide dismutase and catalase in brain regions and liver during (-)deprenyl infusion in female rats
9. The ability of (-)deprenyl to increase superoxide dismutase activities in the rat is tissue and brain region selective
10. The optimal dosage of (-)deprenyl for increasing superoxide dismutase activities in several brain regions decreases with age in male Fischer 344 rats
11. The effect of a long term (6 months) treatment with (-)deprenyl on antioxidant enzyme activities in selective brain regions in old female F-344 rats
12. (-)Deprenyl increases activities of superoxide dismutase (SOD) in striatum of dog brain
13. Long term treatment with (-)deprenyl reduces the optimal dose as well as the effective dose range for increasing antioxidant enzyme activities in old mouse brain
14. A high dose of long term treatment with deprenyl loses its effect on antioxidant enzyme activities as well as on survivals of Fischer-344 rats
15. Enhancing effect of rasagiline on superoxide dismutase and catalase activities in the dopaminergic system in the rat
16. Inhibition of nitrite formation from hydroxylammoniumchloride: A simple assay for superoxide dismutase
17. Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase B inhibitor
18. Influence of Selegiline and lipoic acid in the life expectancy of immunosuppressed mice
19. Age and sex associated differences in the relative abundance of multiple species of cytochrome P-450 in rat liver microsomes - A separation by HPLC of hepatic microsomal cytochrome P-450 species
20. Long term administration of (-)deprenyl increases mortality in male Wistar rats
21. Effect of long-term administration of pergolide and (-)deprenyl on age related decline in hole board activity and antioxidant enzymes in rats
22. Chronic treatment of aged mice with L-deprenyl produces marked MAO-B inhibition but no beneficial effects on survival, motor performance, or nigral lipofuscin accumulation
23. Age-related alteration in the activities of drug-metabolizing enzymes and contents of sex-specific forms of cytochrome P-450 in liver microsomes from male and female rats
24. Drugs and the ageing liver
25. Chronic treatment of (-)deprenyl prolongs the life span of male Fischer 344 rats: Further evidence
26. Upregulation of antioxidant enzyme activities by deprenyl: Implications for life span extension
27. Assessing the effects of deprenyl on longevity and antioxidant defences in different animal models
28. Age-dependence of the lateral diffusion coefficient of lipids and proteins in the hepatocyte plasma membrane of BN/Bi RijHsd rats as revealed by the smear FRAP technique
29. Pharmacological modifications of endogenous antioxidant enzymes with special reference to the effect of deprenyl: A possible antioxidant strategy
30. The striatal dopamine dependency of life span in male rats: Longevity study with (-)deprenyl
31. The pharmacology of selegiline/(-)deprenyl. New aspects
32. Striatal dopamine, sexual activity and life span. Longevity of rats treated with (-)deprenyl
33. L-Deprenyl reduces brain damage in rats exposed to transient hypoxia-ischemia
34. Trophic effects of selegiline on cultured dopaminergic neurons
35. L-deprenyl potentiates NGF-induced changes in superoxide dismutase mRNA in PC12 cells
36. Protein measurement with the Folin phenol reagent
37. Neuroprotection by (-)deprenyl and related compounds
38. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein)
39. Maintenance of L-deprenyl prolongs life in aged male rats
40. Selegiline as immunostimulant - A novel mechanism of action?
41. Physical-chemical and biochemical differences in liver plasma membranes in aging F-344 rats
42. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase
43. Influence of L-deprenyl treatment on mouse survival kinetics
44. L-Deprenyl and canine longevity: Evidence for an immune mechanism, and implications for human aging
45. Treatment with L-deprenyl prolongs life in elderly dogs
46. Chronic treatment of Syrian hamsters with low-dose selegiline increases life span in females but not males
47. Differential changes in monoamine oxidase-A and -B activity in the aging rat brain
48. Enhanced glial cell line-derived neurotrophic factor mRNA expression upon (-)deprenyl and melatonin treatments
49. L-deprenyl inhibits tumor growth, reduces serum prolactin, and suppresses brain monoamine metabolism in rats with carcinogen-induced mammary tumors
50. Deprenyl reinitiates estrous cycles, reduces serum prolactin, and decreases the incidence of mammary and pituitary tumors in old acyclic rats
51. Antitumor effect of L-deprenyl in rats with carcinogen-induced mammary tumors
52. Effects of L-deprenyl treatment on noradrenergic innervation and immune reactivity in lymphoid organs of young F-344 rats
53. Hepatic and extrahepatic metabolism of deprenyl, a selective monoamine oxidase (MAO)B inhibitor of amphetamines in rats: Sex and strain differences